awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q21198871-1E375D58-1217-47E8-970D-DD99AEF4E585
Q21198871-1E375D58-1217-47E8-970D-DD99AEF4E585
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21198871-1E375D58-1217-47E8-970D-DD99AEF4E585
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
P2860
Q21198871-1E375D58-1217-47E8-970D-DD99AEF4E585
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21198871-1E375D58-1217-47E8-970D-DD99AEF4E585
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f11208502252ce758e26ac7154531e9a4f6e3586
P2860
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.